Cytological and cytogenetic effects of the fluoroquinolone ofloxacin on human periodontal ligament fibroblasts

Journal of Periodontal Research

Volumn 35, Issue 6, 2000, Pages 352-360

  Someya, Tetsuro ^a   Tamura, Yukiko ^a   Tsutsui, Takeki ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

Clastogenicity; Cytological effect; Ofloxacin; Periodontal ligament cells

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; DNA; MESSENGER RNA; OFLOXACIN; PROCOLLAGEN;

ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CYTOLOGY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FIBROBLAST; HUMAN; PERIODONTAL LIGAMENT;

ALKALINE PHOSPHATASE; ANTI-INFECTIVE AGENTS; CELL DIVISION; CELL SURVIVAL; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DNA; FIBROBLASTS; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OFLOXACIN; PERIODONTAL LIGAMENT; PROCOLLAGEN; RNA, MESSENGER;

EID: 0034546841     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2000.035006352.x     Document Type: Article

References (31)

1. Miyake Y, Onoe T, Sagawa H, Takamori A, Suginaka H. In vitro antibacterial activity of ofloxacin against periodontal disease-associated bacteria. J Periodont Res 1988;23: 222-223.
2. Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. J Periodont Res 1995;30:290-293.
3. King A, Phillips I. The comparative in vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother 1986;18(suppl D):1-20.
4. Omori N, Kobayashi H, Tsutsui T. Quantitative comparison of cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts. J Periodont Res 1999;34:290-295.
5. McQueen CA, Way BM, Queener SM, Schlüter G, Williams GM. Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. Toxicol Appl Pharmacol 1991;111:255-262.
6. Shimada H, Itoh S, Hattori C, Tada S, Matsuura Y. Mutagenicity of the new quinolone antibacterial agent levofloxacin. Arzeneim Forsch 1992;42:378-385.
7. Shimada H, Itoh S. Effect of new quinolone antibacterial agents on mammalian chromosomes. J Toxicol Environ Health 1996;47:115-123.
8. Shimada H, Itoh S. Effect of DU-6859 and the related quinolone antibacterial agents on mammalian chromosomes. 31st ICAAC abstr, 1991:1507, Chicago.
9. Shimada H, Ebine Y, Kurosawa Y, Arauchi T. Mutagenicity studies of DL-8280, a new antibacterial drug. Chemotherapy 1984;32:1162-1170.
10. Tsutsui T, Umeda M, Sou M, Maizumi H. Effect of letracycline on cultured mouse cells. Mutat Res 1976; 40:261-268.
11. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996;11:312-324.
12. Galloway SM, Aardema MJ, Ishidate M Jr et al. Report from working group on in vitro tests for chromosomal aberrations. Mutat Res 1994;312:241-261.
13. 1-induced immortalization of cultured skin fibroblasts from a patient with Li-Fraumeni syndrome. Carcinogenesis 1995;16:25-34.
14. Tsutsui T, Hayashi N, Maizumi H, Huff J, Barrett JC. Benzene-, catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutat Res 1997;373:113-123.
15. Tsutsui T, Degen GH, Schiffman D et al. Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res 1984; 44:184-189.
16. Umezawa N, Arakane K, Ryu A, Mashiko S, Hirobe M, Nagano T. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch Biochem Biophys 1997;342:275-281.
17. Shen LL, Pernet AG. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drug is DNA. Proc Natl Acad Sci U S A 1985;82:307-311.
18. Hussy P, Maass G, Tummler B, Grosse F, Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase α primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother 1986;29:1073-1078.
19. Miller KG, Liu LF, Englund PT. A homogeneous type II DNA topoisomerase from the HeLa cell nuclei. J Biol Chem 1981;256:9334-9339.
20. Rusquet R, Bonhommet M, David JC. Quinolone anti-biotics inhibit eucaryotic DNA polymerase α and β, terminal deoxynucleotidyl transferase but not DNA ligase. Biochem Biophys Res Commun 1984;121:762-769.
21. Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28:716-721.
22. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T, Kizaki H. Topoisomerase inhibitors induce apoptosis in thymocyles. Biochim Biophys Acta 1993;1175:147-154.
23. Shimoda K, Kato M. Apoptotic photoreceptor cell death induced by quinolone phototoxicity in mice. Toxicol Lett 1999;105:9-15.
24. Menshik M, Neumuller J, Steiner CW et al. Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. Antimicrob Agents Chemother 1997;41:2562-2565.
25. Erhart B, Chan PJ, Patton WC, King A. Ofloxacin: the next generation of antibiotic in sperm and embryo cultures for assisted reproductive technologies. Fertil Steril 1998; 69:246-251.
26. Fabris G, Trombelli L, Schincaglia GP, Cavallini R, Calura G, del Senno L. Effects of a fibrin-fibronectin sealing system on proliferation and type I collagen synthesis of human PDL fibroblasts in vitro. J Clin Periodoniol 1998;25: 11-14.
27. Mitelman F, Kolnig A-M, Strombeck B et al. No cytogenetic effects of quinolone treatment in humans. Antimicrob Agents Chemother 1988;32:936-937.
28. Riesbeck K, Andersson J, Gullberg M, Forsgren A. Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc Natl Acad Sci U S A 1989;86:2809-2813.
29. Bredberg A, Brant M, Riesbeck K, Azou Y, Forsgren A. 4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat Res 1989;211:171-180.
30. Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988;10(suppl 1): S141-S146.
31. Halkin H. Adverse effects of the fluoroquinolones. Rev Infect Dis 1988;10(suppl 1):S258-S261.